Medtronic plc
MDT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Společnost Medtronic plc vyvíjí, vyrábí a prodává lékařské terapie založené na přístrojích zdravotnickým systémům, lékařům, klinickým lékařům a pacientům po celém světě. Jeho segment kardiovaskulárního portfolia nabízí implantabilní kardiostimulátory, defibrilátory kardiostimulátorů a zařízení pro resynchronizační terapii srdce; produkty pro srdeční ablaci; systémy vložitelných monitorů srdce; produkty TYRX; vzdálené monitorování a software zaměřený na pacienta. Poskytuje také aortální chlopně, přípravky pro chirurgickou výměnu a opravy chlopní, endovaskulární stentové štěpy a příslušenství a transkatetrové plicní chlopně; a perkutánní koronární intervenční přípravky, perkutánní angioplastické balónky a produkty. Segment Lékařské chirurgické portfolio společnosti nabízí chirurgické sešívací přístroje, nástroje pro utěsnění cév, uzavírání ran, elektrochirurgické produkty, chirurgickou umělou inteligenci a robotické chirurgické produkty, mechanická zařízení kýly, síťové implantáty, gynekologii a plicní produkty a různé terapie k léčbě nemocí, stejně jako produkty v oblasti minimálně invazivní gastrointestinální a hepatologické diagnostiky a terapie, monitorování pacientů, řízení dýchacích cest a ventilační terapie a onemocnění ledvin. Segment Neuroscience Portfolio nabízí produkty pro chirurgy páteře, neurochirurgy, neurology, specialisty na zvládání bolesti, anesteziology, ortopedické chirurgy, urology, urogynekology, intervenční radiology, specialisty na uši, nos a krk a systémy, které zahrnují energetické chirurgické nástroje. Poskytuje také chirurgické zákroky s obrazovým vedením a intraoperační zobrazovací systémy a robotické naváděcí systémy používané při roboticky asistovaných páteřních zákrocích; a terapie vaskulatury v mozku a jeho okolí. Segment diabetes Operating Unit společnosti nabízí inzulinové pumpy a spotřební materiál, systémy nepřetržitého monitorování glukózy, inteligentní inzulínové pero a spotřební materiál a zásoby. Společnost byla založena v roce 1949 a sídlí v irském Dublinu.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
95000
Založení
1973-05-02
Podobné společnosti
$ 353.94
- $ 2.09
$ 455.55
- $ 21.06
$ 99.98
- $ 0.05
$ 848.98
- $ 3.01
$ 415.16
+ $ 5.69
$ 50.17
+ $ 0.51
$ 83.48
+ $ 0.09
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 35.48 | 33.54 | 32.36 | 31.23 | 31.69 | 30.12 | 28.91 | 30.56 | 29.95 | 29.71 | 28.83 | 20.26 | 17.01 | 16.59 | 16.18 | 15.93 | 15.82 | |
| Cost of Revenues | 13.50 | 11.63 | 11.22 | 10.72 | 10.15 | 10.48 | 9.42 | 9.16 | 9.06 | 9.29 | 9.14 | 6.31 | 4.33 | 4.13 | 3.89 | 3.91 | 3.81 | |
| Gross Profit | 21.98 | 21.91 | 21.15 | 20.51 | 21.54 | 19.63 | 19.49 | 21.40 | 20.90 | 20.42 | 19.69 | 13.95 | 12.67 | 12.46 | 12.30 | 12.02 | 12.01 |
| Revenue | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 9.02 | 8.96 | 8.58 | 8.93 | 8.29 | 8.40 | 7.92 | 8.59 | 8.09 | 7.98 | |
| Cost of Revenues | 3.17 | 3.56 | 3.63 | 3.15 | 2.78 | 2.95 | 2.76 | 3.04 | 2.78 | 2.76 | |
| Gross Profit | 5.85 | 5.41 | 4.95 | 5.78 | 5.51 | 5.46 | 5.15 | 5.55 | 5.31 | 5.22 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 2.70 | 2.75 | 2.49 | 2.33 | 2.33 | 2.25 | 2.19 | 2.22 | 1.64 | 1.48 | 1.56 | 1.49 | 1.51 | 1.48 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 10.42 | 10.29 | 10.15 | 10.11 | 10.42 | 9.97 | 9.71 | 9.47 | 6.90 | 5.85 | 5.70 | 6.07 | 5.53 | 5.79 | |
| Depreciation & Amortization | 3.08 | 2.86 | 2.65 | 2.70 | 3.18 | 3.45 | 3.45 | 2.66 | 2.64 | 2.92 | 2.82 | 1.31 | 0.85 | 0.82 | 0.86 | 0.80 | 0.77 | |
| Total Operating Expenses | 15.64 | 15.95 | 16.00 | 14.68 | 15.63 | 14.74 | 14.27 | 14.77 | 14.56 | 14.11 | 13.73 | 9.40 | 7.85 | 7.69 | 7.90 | 7.04 | 7.74 | |
| Operating Income | 6.34 | 5.96 | 5.14 | 5.49 | 5.75 | 4.48 | 4.79 | 6.27 | 6.65 | 5.33 | 5.29 | 3.77 | 4.08 | 4.64 | 4.70 | 4.17 | 4.37 |
| Operating Income | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Depreciation & Amortization | 0.91 | 0.59 | 0.75 | 0.84 | 0.68 | 0.68 | 0.66 | 0.65 | 0.65 | 0.67 | ||
| Total Operating Expenses | 4.08 | 3.72 | 3.50 | 4.34 | 3.87 | 3.86 | 3.88 | 4.49 | 3.82 | 3.88 | ||
| Operating Income | 1.77 | 1.69 | 1.45 | 1.44 | 1.65 | 1.60 | 1.28 | 1.05 | 1.48 | 1.34 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.15 | 0.00 | 0.00 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 0.37 | 0.43 | 0.39 | 0.27 | 0.24 | 0.20 | 0.17 | 0.16 | |
| Interest Expense | 0.71 | 0.73 | 0.72 | 0.64 | 0.55 | 0.93 | 1.09 | 1.44 | 1.15 | 1.09 | 1.39 | 0.67 | 0.38 | 0.39 | 0.15 | 0.45 | 0.25 | |
| Other Expense | -0.78 | -0.33 | -0.31 | -0.12 | -0.24 | -0.59 | -0.74 | 0.01 | 0.08 | -0.98 | -0.67 | -0.79 | -1.01 | -0.37 | -0.10 | -0.98 | -0.05 | |
| IBT | 5.56 | 5.63 | 4.84 | 5.36 | 5.52 | 3.90 | 4.06 | 5.20 | 5.68 | 4.60 | 4.34 | 3.49 | 3.71 | 4.25 | 4.15 | 3.72 | 3.97 | |
| Income Tax Expense | 0.92 | 0.94 | 1.13 | 1.58 | 0.46 | 0.27 | -0.75 | 0.55 | 2.58 | 0.58 | 0.80 | 0.81 | 0.64 | 0.78 | 0.73 | 0.63 | 0.87 | |
| Net Income | 4.61 | 4.66 | 3.68 | 3.76 | 5.04 | 3.61 | 4.79 | 4.63 | 3.10 | 4.03 | 3.54 | 2.68 | 3.07 | 3.47 | 3.62 | 3.10 | 3.10 |
| Net Income | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.12 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Interest Expense | 0.18 | 0.18 | 0.18 | 0.17 | 0.18 | 0.21 | 0.17 | 0.20 | 0.19 | 0.18 | ||
| Other Expense | -0.37 | -0.09 | -0.14 | -0.18 | -0.11 | -0.04 | -0.01 | -0.20 | -0.01 | -0.03 | ||
| IBT | 1.40 | 1.60 | 1.30 | 1.26 | 1.54 | 1.56 | 1.27 | 0.86 | 1.47 | 1.31 | ||
| Income Tax Expense | 0.25 | 0.22 | 0.26 | 0.20 | 0.24 | 0.28 | 0.22 | 0.20 | 0.14 | 0.40 | ||
| Net Income | 1.14 | 1.37 | 1.04 | 1.06 | 1.29 | 1.27 | 1.04 | 0.65 | 1.32 | 0.91 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $2.83 | $3.75 | $2.68 | $3.57 | $3.44 | $2.29 | $2.92 | $2.51 | $2.44 | $3.06 | $3.40 | $3.43 | $2.87 | $2.80 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $2.82 | $3.73 | $2.66 | $3.54 | $3.41 | $2.27 | $2.89 | $2.48 | $2.41 | $3.02 | $3.37 | $3.41 | $2.86 | $2.79 | |
| Shares Outstanding | 1.28 | 1.29 | 1.33 | 1.33 | 1.34 | 1.34 | 1.34 | 1.35 | 1.36 | 1.38 | 1.41 | 1.10 | 1.00 | 1.02 | 1.05 | 1.08 | 1.11 | |
| Diluted Shares Outstanding | 1.29 | 1.29 | 1.33 | 1.33 | 1.35 | 1.35 | 1.35 | 1.36 | 1.37 | 1.39 | 1.43 | 1.11 | 1.01 | 1.03 | 1.06 | 1.08 | 1.11 |
| Per Share Data | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Shares Outstanding | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.29 | 1.32 | 1.33 | 1.33 | ||
| Diluted Shares Outstanding | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 | 1.30 | 1.33 | 1.33 | 1.33 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1.28 | 2.22 | 1.28 | 1.54 | 3.71 | 3.59 | 4.14 | 4.39 | 3.67 | 4.97 | 2.88 | 4.84 | 1.40 | 0.98 | 1.25 | 1.38 | 1.40 | |
| Short Term Investments | 6.72 | 6.75 | 6.72 | 6.42 | 6.86 | 7.22 | 6.81 | 5.46 | 7.56 | 8.74 | 9.76 | 14.64 | 12.84 | 10.09 | 1.34 | 1.05 | 2.38 | |
| Total Cash & ST Investments | 8.01 | 8.97 | 8.01 | 7.96 | 10.57 | 10.82 | 10.95 | 9.85 | 11.23 | 13.71 | 12.63 | 19.48 | 14.24 | 11.07 | 2.59 | 2.43 | 3.78 | |
| Accounts Receivable | 6.13 | 6.52 | 6.13 | 6.00 | 5.55 | 5.46 | 4.65 | 6.22 | 5.99 | 5.59 | 6.26 | 6.45 | 4.55 | 4.20 | 3.81 | 3.82 | 3.34 | |
| Inventory | 5.22 | 5.48 | 5.22 | 5.29 | 4.62 | 4.31 | 4.23 | 3.75 | 3.58 | 3.34 | 3.47 | 3.46 | 1.73 | 1.71 | 1.80 | 1.70 | 1.48 | |
| Other Current Assets | 2.59 | 2.86 | 2.59 | 2.43 | 2.32 | 1.96 | 2.21 | 2.14 | 2.19 | 1.87 | 1.23 | 1.45 | 0.70 | 0.74 | 1.32 | 1.17 | 1.25 | |
| Total Current Assets | 21.94 | 23.81 | 21.94 | 21.68 | 23.06 | 22.55 | 22.03 | 21.97 | 22.98 | 24.87 | 23.60 | 30.84 | 21.21 | 17.75 | 9.84 | 9.12 | 9.84 |
| Current Assets | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1.27 | 2.22 | 1.24 | 1.39 | 1.31 | 1.28 | 1.62 | 1.31 | 1.34 | 1.54 | |
| Short Term Investments | 6.85 | 6.75 | 6.68 | 6.60 | 6.53 | 6.72 | 6.70 | 6.42 | 6.54 | 6.42 | |
| Total Cash & ST Investments | 8.12 | 8.97 | 7.92 | 7.99 | 7.84 | 8.01 | 8.32 | 7.73 | 7.88 | 7.96 | |
| Accounts Receivable | 6.26 | 6.52 | 6.12 | 6.26 | 6.01 | 6.13 | 5.97 | 5.93 | 5.81 | 6.00 | |
| Inventory | -0.37 | 5.48 | 5.61 | 5.48 | 5.41 | 5.22 | 5.73 | 5.75 | 5.67 | 5.29 | |
| Other Current Assets | 9.21 | 2.86 | 2.87 | 2.71 | 2.68 | 2.59 | 2.50 | 2.66 | 2.52 | 2.43 | |
| Total Current Assets | 23.22 | 23.81 | 22.51 | 22.44 | 21.95 | 21.94 | 22.51 | 22.08 | 21.87 | 21.68 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 7.14 | 6.84 | 6.13 | 5.57 | 5.41 | 5.22 | 4.83 | 4.68 | 4.60 | 4.36 | 4.84 | 4.70 | 2.39 | 2.49 | 2.47 | 2.51 | 2.42 | |
| Goodwill | 40.99 | 41.74 | 40.99 | 41.43 | 40.50 | 41.96 | 39.84 | 39.96 | 39.54 | 38.52 | 41.27 | 40.53 | 10.59 | 10.33 | 9.93 | 9.54 | 8.39 | |
| Intangible Assets | 13.23 | 11.67 | 13.23 | 14.84 | 15.60 | 17.74 | 19.06 | 20.56 | 21.72 | 23.41 | 26.90 | 28.10 | 2.29 | 2.67 | 2.65 | 2.78 | 2.56 | |
| Long-Term Investments | 1.62 | 0.00 | 0.00 | 1.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 7.71 | 6.12 | 4.63 | |
| Other Long-Term Assets | 1.42 | 7.62 | 7.70 | 2.32 | 6.41 | 5.61 | 4.93 | 2.53 | 2.54 | 8.66 | 2.94 | 2.51 | 1.46 | 1.32 | 0.31 | 0.36 | 0.25 | |
| Total Long-Term Assets | 68.05 | 67.87 | 68.05 | 69.27 | 67.92 | 70.53 | 68.66 | 67.73 | 68.41 | 74.94 | 75.95 | 75.84 | 16.73 | 17.05 | 23.25 | 21.31 | 18.25 | |
| Total Assets | 89.98 | 91.68 | 89.98 | 90.95 | 90.98 | 93.08 | 90.69 | 89.69 | 91.39 | 99.82 | 99.55 | 106.69 | 37.94 | 34.79 | 33.08 | 30.42 | 28.09 |
| Long-Term Assets | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | -0.50 | 6.84 | 6.59 | 6.44 | 6.28 | 6.13 | 5.84 | 5.74 | 5.67 | 5.57 | |
| Goodwill | 42.01 | 41.74 | 40.82 | 41.16 | 41.08 | 40.99 | 41.16 | 40.82 | 41.44 | 41.43 | |
| Intangible Assets | 11.22 | 11.67 | 12.19 | 12.42 | 12.82 | 13.23 | 13.69 | 14.06 | 14.43 | 14.84 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.64 | |
| Other Long-Term Assets | 15.02 | 7.62 | 7.86 | 7.58 | 7.62 | 7.70 | 7.64 | 7.39 | 7.37 | 2.32 | |
| Total Long-Term Assets | 67.75 | 67.87 | 67.46 | 67.60 | 67.80 | 68.05 | 68.32 | 68.01 | 68.91 | 69.27 | |
| Total Assets | 90.97 | 91.68 | 89.97 | 90.04 | 89.75 | 89.98 | 90.84 | 90.09 | 90.78 | 90.95 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.41 | 2.45 | 2.41 | 2.66 | 2.28 | 2.11 | 2.00 | 1.95 | 1.63 | 1.73 | 1.71 | 1.61 | 0.74 | 0.62 | 0.57 | 0.51 | 0.42 | |
| Short-Term Debt | 1.28 | 2.87 | 1.09 | 0.20 | 3.74 | 0.01 | 2.78 | 0.84 | 2.06 | 7.52 | 0.99 | 2.43 | 1.61 | 0.36 | 3.27 | 1.72 | 2.58 | |
| Other Current Liabilities | 6.75 | 7.56 | 5.96 | 5.35 | 6.38 | 6.39 | 5.59 | 5.68 | 6.40 | 0.03 | 4.46 | 5.13 | 3.20 | 2.36 | 2.02 | 2.48 | 2.13 | |
| Current Liabilities | 10.79 | 12.88 | 10.79 | 9.05 | 12.39 | 8.51 | 10.37 | 8.47 | 10.08 | 14.22 | 7.17 | 9.17 | 5.57 | 3.29 | 5.86 | 4.71 | 5.12 |
| Current Liabilities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.56 | 2.45 | 2.29 | 2.38 | 2.29 | 2.41 | 1.99 | 2.17 | 2.24 | 2.66 | |
| Short-Term Debt | 2.43 | 2.87 | 2.62 | 3.72 | 1.55 | 1.09 | 1.03 | 1.34 | 0.52 | 0.20 | |
| Other Current Liabilities | 6.14 | 6.20 | 5.81 | 5.15 | 5.38 | 5.96 | 5.66 | 5.06 | 5.28 | 5.35 | |
| Current Liabilities | 11.53 | 12.88 | 11.84 | 12.20 | 10.29 | 10.79 | 9.79 | 9.66 | 9.05 | 9.05 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 23.88 | 25.64 | 23.93 | 24.34 | 20.37 | 26.38 | 22.02 | 24.49 | 23.70 | 25.92 | 30.25 | 33.75 | 10.32 | 10.29 | 7.36 | 8.11 | 6.94 | |
| Capital Leases | 0.90 | 0.06 | 0.90 | 0.06 | 0.06 | 0.07 | 0.05 | 0.02 | 0.03 | 0.03 | 0.13 | 0.15 | 0.14 | 0.17 | 0.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.52 | 0.40 | 0.52 | 0.71 | 0.88 | 1.03 | 1.17 | 1.28 | 1.42 | 2.98 | 3.73 | 4.70 | 0.39 | 0.34 | 1.62 | 0.72 | 0.68 | |
| Total Liabilities | 39.56 | 43.42 | 39.56 | 39.28 | 38.26 | 41.48 | 39.82 | 39.48 | 40.57 | 49.40 | 47.72 | 53.46 | 18.50 | 16.12 | 15.97 | 14.46 | 13.46 |
| Long-Term Liabilities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 26.18 | 25.64 | 23.99 | 24.61 | 26.31 | 23.93 | 24.15 | 23.74 | 24.46 | 24.34 | |
| Capital Leases | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 | 0.90 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Def. Tax Liability | 0.42 | 0.40 | 0.45 | 0.47 | 0.50 | 0.52 | 0.62 | 0.69 | 0.69 | 0.71 | |
| Total Liabilities | 42.84 | 43.42 | 40.36 | 41.33 | 41.59 | 39.56 | 38.84 | 38.44 | 39.41 | 39.28 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 | |
| Retained Earnings | 30.40 | 31.48 | 30.40 | 30.39 | 30.25 | 28.59 | 28.13 | 26.27 | 24.38 | 23.36 | 53.93 | 54.41 | 19.94 | 19.06 | 17.48 | 16.09 | 14.83 | |
| Comprehensive Income | -3.32 | -4.28 | -3.32 | -3.50 | -2.27 | -3.49 | -3.56 | -2.71 | -1.79 | -2.61 | -2.10 | -1.18 | -0.60 | -0.49 | -0.47 | -0.22 | -0.31 | |
| Total Common Equity | 50.21 | 48.02 | 50.21 | 51.48 | 52.55 | 51.43 | 50.74 | 50.09 | 50.72 | 50.29 | 51.83 | 53.23 | 19.44 | 18.67 | 17.11 | 15.97 | 14.63 |
| Total Common Equity | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retained Earnings | 31.61 | 31.48 | 31.32 | 30.92 | 30.55 | 30.40 | 30.66 | 30.26 | 30.27 | 30.39 | |
| Comprehensive Income | -4.60 | -4.28 | -2.84 | -3.25 | -3.41 | -3.32 | -3.46 | -3.38 | -3.67 | -3.50 | |
| Total Common Equity | 47.89 | 48.02 | 49.39 | 48.49 | 47.95 | 50.21 | 51.79 | 51.46 | 51.18 | 51.48 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 26.05 | 28.52 | 25.02 | 24.36 | 24.11 | 26.39 | 24.80 | 25.32 | 25.76 | 33.44 | 31.24 | 36.19 | 11.93 | 10.65 | 10.63 | 9.84 | 9.52 | |
| Book Value | 50.42 | 48.26 | 50.42 | 51.67 | 52.72 | 51.60 | 50.87 | 50.21 | 50.82 | 50.42 | 51.83 | 53.23 | 19.44 | 18.67 | 17.11 | 15.97 | 14.63 |
| Other | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.24 | 0.23 | 0.23 | 0.22 | 0.21 | 0.21 | 0.20 | 0.19 | 0.19 | 0.18 | |
| Book Value | 47.89 | 48.02 | 49.39 | 48.49 | 47.95 | 50.21 | 51.79 | 51.46 | 51.18 | 51.48 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 3.68 | 4.69 | 3.68 | 3.78 | 5.06 | 3.63 | 4.81 | 4.65 | 3.10 | 4.02 | 3.54 | 2.68 | 3.07 | 3.47 | 3.62 | 3.10 | 3.10 | |
| Depreciation & Amortization | 2.65 | 2.86 | 2.65 | 2.70 | 2.71 | 2.70 | 2.66 | 2.66 | 2.64 | 2.92 | 2.82 | 1.31 | 0.85 | 0.82 | 0.86 | 0.80 | 0.77 | |
| Stock-Based Compensation | 0.39 | 0.43 | 0.39 | 0.36 | 0.36 | 0.34 | 0.30 | 0.29 | 0.34 | 0.35 | 0.38 | 0.44 | 0.15 | 0.15 | 0.16 | 0.20 | 0.23 | |
| Change Working Capital | -0.48 | -1.05 | -0.48 | -0.97 | -0.89 | -0.70 | 0.06 | -1.08 | -0.17 | 0.14 | -1.09 | 1.56 | 0.22 | 0.23 | -0.10 | -1.01 | -0.32 | |
| Change In Accounts Receivable | -0.39 | -0.43 | -0.39 | -0.58 | -0.48 | -0.76 | 1.29 | -0.58 | -0.28 | -0.08 | -0.44 | -0.41 | -0.07 | 0.00 | -0.25 | -0.34 | -0.27 | |
| Change In Accounts Payable | 0.39 | 0.21 | 0.39 | 0.70 | 0.21 | 0.53 | -0.04 | 0.40 | 0.07 | 0.36 | -0.07 | 1.62 | -0.12 | 0.42 | 0.18 | -0.04 | 0.26 | |
| Change In Inventories | -0.14 | -0.29 | -0.14 | -0.94 | -0.56 | 0.08 | -0.58 | -0.27 | -0.19 | -0.23 | -0.19 | -0.28 | -0.04 | 0.09 | -0.19 | -0.10 | 0.16 | |
| Other Non-cash Items | 0.75 | 0.43 | 1.06 | 0.40 | 0.71 | 0.69 | 0.72 | 0.79 | -0.31 | -0.09 | 0.03 | -0.16 | 0.89 | 0.15 | -0.17 | 0.50 | 0.21 | |
| Cash from Operations | 6.79 | 0.00 | 0.00 | 6.04 | 7.35 | 6.24 | 7.23 | 7.01 | 4.68 | 6.88 | 5.22 | 4.90 | 4.96 | 4.88 | 4.38 | 3.74 | 4.13 |
| Cash Flow From Operating Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.14 | 1.37 | 1.05 | 1.06 | 1.29 | 1.28 | 1.04 | 0.65 | 1.32 | 0.91 | |
| Depreciation & Amortization | 0.84 | 0.75 | 0.75 | 0.84 | 0.68 | 0.68 | 0.66 | 0.65 | 0.65 | 0.67 | |
| Stock-Based Compensation | 0.09 | 0.18 | 0.09 | 0.09 | 0.10 | 0.16 | 0.08 | 0.09 | 0.08 | 0.15 | |
| Change Working Capital | 0.70 | -1.42 | -1.15 | 0.45 | 0.46 | 0.91 | -0.91 | 0.92 | 0.51 | -1.10 | |
| Change In Accounts Receivable | 0.01 | -0.21 | 0.29 | -0.25 | 0.00 | -0.29 | 0.11 | -0.25 | -0.02 | -0.28 | |
| Change In Accounts Payable | 0.70 | -0.18 | -0.60 | 0.37 | 0.55 | -0.10 | -0.60 | 0.64 | 0.45 | -0.03 | |
| Change In Inventories | -0.13 | -0.30 | -0.37 | 0.19 | -0.20 | -0.06 | -0.22 | 0.39 | 0.09 | -0.21 | |
| Other Non-cash Items | 0.07 | 0.05 | 0.19 | 0.33 | 0.17 | -2.03 | 0.02 | 0.71 | 0.12 | 0.06 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.59 | -1.86 | -1.59 | -1.46 | -1.37 | -1.36 | -1.21 | -1.13 | -1.07 | -1.25 | -1.05 | -0.57 | -0.40 | -0.46 | -0.53 | -0.55 | -0.64 | |
| Acquisitions | -0.21 | -0.10 | -0.21 | -1.87 | -0.09 | -0.99 | -0.49 | -1.83 | 5.92 | -1.32 | -1.21 | -14.88 | -0.39 | -0.82 | -0.62 | -1.33 | -0.35 | |
| Investments | -7.75 | -8.23 | -7.75 | -7.51 | -9.88 | -11.81 | -11.04 | -2.53 | -3.20 | -4.37 | -5.41 | -7.58 | -10.90 | -9.97 | -8.08 | -6.38 | -7.44 | |
| Sales of Investment | 7.44 | 8.50 | 7.44 | 7.34 | 9.69 | 11.35 | 9.57 | 4.68 | 4.23 | 5.36 | 9.92 | 5.89 | 8.11 | 8.20 | 6.10 | 6.44 | 3.75 | |
| Other Investing Activities | -0.26 | 0.00 | 0.00 | 0.00 | -0.01 | -0.05 | -0.04 | 0.04 | -0.02 | 0.02 | -0.01 | 0.09 | -0.03 | -0.01 | 0.44 | 0.00 | -0.09 | |
| Cash from Investing | -2.37 | 0.00 | 0.00 | -3.49 | -1.66 | -2.87 | -3.20 | -0.77 | 5.86 | -1.57 | 2.25 | -17.06 | -3.59 | -3.05 | -2.68 | -1.82 | -4.76 |
| Cash Flow From Investing Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.44 | -0.47 | -0.50 | -0.46 | -0.48 | -0.40 | -0.52 | -0.43 | -0.35 | -0.46 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | -0.10 | 0.00 | 0.00 | -0.14 | -0.05 | -0.02 | |
| Investments | -2.37 | -2.10 | -2.10 | -2.13 | -2.07 | -2.14 | -1.88 | -2.33 | -2.02 | -1.49 | |
| Sales of Investment | 2.02 | 1.95 | 2.01 | 2.24 | 1.92 | 2.18 | 2.16 | 2.30 | 1.81 | 1.59 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -1.70 | 0.00 | 0.00 | -0.60 | 0.00 | -10.53 | -6.11 | -7.95 | -7.66 | -0.87 | -5.27 | -1.42 | -1.87 | -4.91 | -0.02 | -2.60 | -0.46 | |
| Debt Issued | 3.38 | 3.49 | 0.66 | 0.85 | -2.27 | 12.12 | 5.58 | 7.52 | -0.02 | 3.07 | 0.33 | 25.68 | 3.14 | 4.93 | 0.82 | 2.92 | 9.98 | |
| Issuance of Common Stock | 0.28 | 0.00 | 0.00 | 0.31 | 0.43 | 0.47 | 0.66 | 0.99 | 0.40 | 0.43 | 0.49 | 0.65 | 1.31 | 0.27 | 0.10 | 0.09 | 0.17 | |
| Repurchase of Common Stock | -2.14 | -3.24 | -2.14 | -0.65 | -2.54 | -0.65 | -1.33 | -2.88 | -2.17 | -3.54 | -2.83 | -1.92 | -2.55 | -1.25 | -1.44 | -1.14 | -1.03 | |
| Dividends Paid | -3.67 | 0.00 | 0.00 | -3.62 | -3.38 | -3.12 | -2.89 | -2.69 | -2.49 | -2.38 | -2.14 | -1.34 | -1.12 | -1.06 | -1.02 | -0.97 | -0.91 | |
| Other Financing Activities | 2.64 | 0.00 | 0.00 | -0.10 | 0.16 | 9.69 | 5.47 | 7.10 | -0.03 | 3.07 | 0.21 | 19.98 | 3.31 | 4.85 | 0.63 | 2.62 | 3.00 | |
| Cash from Financing | -4.45 | 0.00 | 0.00 | -4.96 | -5.34 | -4.14 | -4.20 | -5.43 | -11.95 | -3.28 | -9.54 | 15.95 | -0.92 | -2.10 | -1.76 | -2.01 | 0.76 |
| Cash Flow From Financing Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt Issued | 0.00 | 28.61 | 0.09 | 1.91 | -1.72 | 0.46 | 2.84 | -0.16 | 0.10 | 0.10 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.11 | -0.37 | -0.12 | -0.27 | -0.18 | -0.29 | -2.49 | -1.63 | -0.13 | -0.23 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -0.26 | 0.93 | -0.26 | -2.17 | 0.12 | -0.55 | -0.25 | 0.72 | -1.30 | 2.09 | -1.97 | 3.44 | 0.48 | -0.26 | -0.13 | -0.02 | 0.13 | |
| Closing Cash Balance | 1.28 | 2.22 | 1.28 | 1.54 | 3.71 | 3.59 | 4.14 | 4.39 | 3.67 | 4.97 | 2.88 | 4.84 | 1.40 | 0.98 | 1.25 | 1.38 | 1.40 |
| Cash position | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -0.14 | -1.27 | -2.22 | 0.98 | -0.15 | 0.08 | 0.03 | -0.34 | 0.31 | -0.03 | |
| Closing Cash Balance | 1.15 | 0.00 | 0.00 | 2.22 | 1.24 | 1.39 | 1.31 | 1.28 | 1.62 | 1.31 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 5.20 | 5.19 | 5.20 | 4.58 | 5.98 | 4.89 | 6.02 | 5.87 | 3.62 | 5.63 | 4.17 | 4.33 | 4.56 | 4.43 | 3.85 | 3.19 | 3.50 | |
| Real Free Cash Flow | 4.81 | 4.76 | 4.81 | 4.23 | 5.62 | 4.54 | 5.72 | 5.58 | 3.27 | 5.28 | 3.80 | 3.89 | 4.42 | 4.27 | 3.69 | 3.00 | 3.27 |
| Free Cash Flow | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 2.30 | 0.46 | 0.58 | 2.07 | 2.10 | 0.55 | 0.47 | 2.35 | 2.13 | 0.20 | |
| Real Free Cash Flow | 2.21 | 0.28 | 0.50 | 1.98 | 2.00 | 0.40 | 0.38 | 2.26 | 2.04 | 0.05 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 28.2 | 26.9 | 179.3 |
| P/S | 3.7 | 3.8 | 390.6 |
| P/B | 2.7 | 2.6 | 113.4 |
| P/FCF | 27.4 | 22.4 | 149.9 |
| Market cap | $118.3 | $108.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 30.4 % | 0 % |
| Debt to Income | 620 % | 621.6 % | 0 % |
| Debt to Free cash flow | 576.9 % | 21.3 % | 0 % |
| Interest expense percentage | 11.2 % | 13.9 % | 11.2 % |
| Current ratio | 2 | 2.4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 9.6 % | 11.1 % | 0 % |
| ROA | 5.1 % | 5.9 % | 0 % |
| CapEx to Revenue | 5.3 % | 3.9 % | 6 % |
| RaD to Revenue | 0 % | 8.2 % | 0 % |
| ROEM | 373,515.8 | 169376.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 61.9 % | 69.8 % | 61.9 % |
| Operating margin | 17.9 % | 21 % | 17.9 % |
| Net margin | 13 % | 15.4 % | 13 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 2.2 % | 0 % |
| Dividend payout percentage | 0 % | 56.9 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 1,288.2 mil | 1,247.5 mil |
| Employee count | 95.0 tis | 80.5 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
